| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |